Federal health officials invited tech companies and lobbyists to private sessions to accelerate AI adoption in healthcare. These closed-door meetings prioritize industry input over public transparency. The move suggests a fast-track approach to integration. Practitioners should expect new regulatory frameworks that favor commercial vendors and industry lobbyists over open academic standards.